Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Short-term Investments (2024 - 2026)

Updated

Hemab Therapeutics Holdings' Short-term Investments was $191.09 million in Q3 2026, down 13.2% from the prior quarter.

Analysis

Hemab Therapeutics Holdings (COAG) Short-term Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, Short-term Investments at Hemab Therapeutics Holdings came in at $97.51 million, up 600.6% from FY2024.

  • In earlier years, Short-term Investments was $13.92 million in FY2024.
  • Quarterly Short-term Investments has moved between $13.92 million (Q4 2024) and $220.09 million (Q2 2026) over five years.
  • Per Business Quant data, COAG's Short-term Investments in the three quarters before Q3 2026 was $220.09 million (Q2 2026), $113.67 million (Q1 2026) and $97.51 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 191.09 Mn
Jun 30, 2026 220.09 Mn
Mar 31, 2026 113.67 Mn
Dec 31, 2025 97.51 Mn
Dec 31, 2024 13.92 Mn
API Access

Hemab Therapeutics Holdings Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=COAG&period=max&api_key=YOUR_API_KEY